Epilepsy in Children and Youth: Advanced Program
OCTOBER 17 - NOVEMBER 28, 2024 | 12:00 PM - 1:00 PM EST | THURSDAYS WEEKLY
This program explores a range of complex topics such as drug resistant epilepsy, polypharmacy, genetics, ketogenic diet, and more. This program is intended for clinicians who are seeking to further their competencies in epileptology.
Next Session
October 17, 2024
12:00 pm – 1:00 pm
S1. Polypharmacy
Case Support
Healthcare providers can present your de-identified case for advice, support and written recommendations.
This series is facilitated by McMaster Children’s Hospital.
Syllabus
This Group Learning program meets the certification criteria of the College of Family Physicians of Canada and has been certified by Continuing Professional Development, Faculty of Medicine, University of Toronto for up for up to 1.0 Mainpro+ credits.
This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, approved by Continuing Professional Development, Faculty of Medicine, University of Toronto. You may claim a maximum of 1.0 hours.
- Identify evidence-supported indications and dosing
- Recognize common drug-drug interactions and side effects
- Recognize epilepsy can be a genetic condition
- Identify patients with epilepsy that may benefit from genetic testing
- Describe the process of genetic testing for epilepsy in Ontario
- Describe the underlying mechanism of the ketogenic diet
- Identify how the diet is monitored in children with epilepsy
- Recognize clinical considerations for ketogenic diet as a treatment option for children living with epilepsy
- Identify the evidence-supported indications and dosing for cannabinoid therapy in epilepsy
- Recognize common drug-drug interactions, side effects, and practical considerations in using cannabinoids in pediatric epilepsy
- Describe the ways in which healthcare professionals can support and facilitate families in accessing medical cannabis
- Identify drug resistant epilepsy (DRE)
- Recognize when to refer to a paediatric epilepsy program, referral pathways available in Ontario
- Describe the importance of counseling regarding DRE
- Recognize issues that may arise as children with epilepsy become teenagers including contraception and pregnancy, driving, and mood disorders
- Identify the risk factors for SUDEP, current preventative measures, and the importance of counselling patients and families
- Recognize factors impacting health care transition for youth with epilepsy
- Identify the most common psychiatry and somatic co-morbidities associated to epilepsy
- Discuss the management of the common psychiatric and somatic co-morbidities associated with epilepsy
Didactics & Recordings
*Available after sessions begin
Clinical Leads
Dr. Kevin Jones, Paediatric Neurologist & Epileptologist
Medical Co-Lead
Dr. Robyn Whitney, Paediatric Neurologist & Epileptologist
Medical Co-Lead
Dr. Rajesh Ramachandran Nair, Paediatric Neurologist & Epileptologist
Medical Co-Lead
Cynthia Sloan Birbeck, Nurse Practitioner
Leah Morgenstern, Registered Nurse
Trevor Dalton, Psychometrist
Nevena Simic, Clinical Neuropsychologist
Kristin Welton, Community Epilepsy Agency Navigator
Epilepsy Niagara